| Literature DB >> 32343118 |
Christian Finley1, Anubha Prashad1, Natasha Camuso1, Corinne Daly1, Armen Aprikian1, Chad G Ball1, James Bentley1, Dhany Charest1, Paola Fata1, Lucy Helyer1, Daniel O'Connell1, Husein Moloo1, Andrew Seely1, Joel Werier1, Toni Zhong1, Craig C Earle1.
Abstract
Summary: During the coronavirus disease 2019 (COVID-19) pandemic, delaying lifesaving cancer surgeries must be done with extreme caution and thoughtfulness. Modelling indicates that delays in high-risk cancer surgeries beyond 6 weeks could affect long-term outcomes for thousands of Canadians. Consequently, it is possible that postponing cancer surgery without consideration of its implications could cost more lives than can be saved by diverting all surgical resources to COVID-19. This article provides general guidance on supporting curative surgical treatment where appropriate and with available resources.Entities:
Mesh：
Year: 2020 PMID： 32343118 DOI： 10.1503/cjs.005620
Source DB: PubMed Journal: Can J Surg ISSN： 0008-428X Impact factor: 2.089